TRML(Delisted)
Tourmaline Bio·NASDAQ
--
--(--)
TRML fundamentals
Tourmaline Bio (TRML) released its earnings on Jun 14, 2021: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Jun 14, 2021
EPS
Revenue
Revenue & Expenses
Key Indicators
Tourmaline Bio (TRML) key financial stats and ratios, covering profitability, financial health, and leverage.
Tourmaline Bio (TRML)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Tourmaline Bio (TRML)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Tourmaline Bio (TRML)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Tourmaline Bio (TRML) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Tourmaline Bio (TRML) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
